
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 16, 2024 for Swaminathan
Filed with BSE ·

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 16, 2024 for Swaminathan
6ix hasn’t read this filing yet.
Follow Indrayani Biotech into a list and get an email when it puts out news.
Follow Indrayani Biotech